Granules pharma share price today
WebSep 30, 2024 · Granules stock price target by the end of 2024, The target value of the first share of Granules for the financial year 2024 is estimated to be Rs 460. And the second … WebAug 24, 2024 · NEW DELHI: Shares of Granules India climbed 3 per cent in Monday's trade after the drug maker said its US-based subsidiary has received approval for Ramelteon …
Granules pharma share price today
Did you know?
WebJan 14, 2024 · A Tale Of Resilience. Shares of Hyderabad-based drugmaker Aurobindo Pharma fell as much as 4.5 per cent to hit an intraday low of Rs 685.85 after it received a warning letter from the US drug ... WebView live GRANULES INDIA chart to track its stock's price action. Find market predictions, GRANULES financials and market news. ... A Promising Stock with Strong Earnings GRANULES INDIA SHARE BUY …
WebFounded. 1989. Bharat Immunologicals & Biologicals Corp. Ltd. is a biotechnology company, which engages in the manufacturing and producing pharmaceutical products such as oral polio vaccines; zinc tablet and diarrhea management kit; and ready to use therapeutic food. It operates through the following business segments: Oral Polio … WebGranules India gets USFDA nod for Gabapentin Tablets; share price falls. Feb 27, 11:54. Granules gets USFDA nod to market generic medication to treat high blood pressure. Feb 27, 09:53. Granules India secures FDA nod to hypertension drug but share price falls. Jan 31, 15:49. Buy Granules India; target of Rs 355: ICICI Direct
Web1 day ago · The Nifty Pharma index closed 0.76 per cent down at 12478.9. NEW DELHI: The Nifty Pharma index closed on a negative note on Thursday. Shares of Aurobindo Pharma (up 0.77 per cent), Pfizer (up 0.51 per cent), Biocon (up 0.2 per cent) and Alkem Laboratories (up 0.13 per cent) ended the day as top gainers in the pack. WebGranules India Limited Share Price Today, Live NSE Stock Price: Get the latest Granules India Limited news, company updates, quotes, offers, annual financial reports, graph, volumes, 52 week high low, buy sell tips, balance sheet, historical charts, market performance, capitalisation, dividends, volume, profit and loss account, research, results …
WebCheck Granules India share price, financial data and complete stock analysis.Get Granules India stock rating based on quarterly result, profit and loss account, balance …
WebApr 10, 2024 · What's the Granules India share price today? Granules India share price was Rs 297.35 as on 03 Apr, 2024, 03:59 PM IST. Granules India share price was up … end of trial period letterWebMeanwhile, amid concern over US markets, pharma stocks were also under pressure. Shares of Gland Pharma, Lupin and Granules India declined 2-2.5% in Monday's trade. … end of tree branchWeb1 day ago · The Nifty Pharma index was trading 0.41 per cent down at 12522.65. ... Laurus(down 2.12 per cent), Granules India(down 1.38 per cent), Ipca Laboratories(down 1.08 per cent), Natco Pharma(down 1.01 per cent) and Sun Pharmaceutical Industries(down 0.74 per cent) were the top losers on the index. ... Covid Cases Today … end of triassicWebSep 30, 2024 · Granules stock price target by the end of 2024, The target value of the first share of Granules for the financial year 2024 is estimated to be Rs 460. And the second indicative price of Granule could offer around Rs 480. dr chipper reviewsWebGranules India Limited Share Price Today, Live NSE Stock Price: Get the latest Granules India Limited news, company updates, quotes, offers, annual financial reports, graph, … dr chipper how to replace belt and bladesWebApr 6, 2024 · Get Granules India Ltd.'s stock analysis, price valuation, corporate actions, and financials from India's independent mutual fund research house. dr chipper reviews reviewsWebJan 2, 2024 · Employees in Chantilly have rated Granules Pharmaceuticals with 3.2 out of 5 for work-life-balance (equal to company-wide rating), 3.2 out of 5 for diversity and inclusion (6.5% higher than company-wide rating), 3 out of 5 for culture and values (3.3% lower than company-wide rating) and 3.5 out of 5 for career opportunities (equal to company ... end of travel testing